<p>A new spin on an old drug could dent demand for Epidiolex, a marijuana-based epilepsy drug. Plus, here's how important Medicare and Medicaid are to UnitedHealth Group's profits.</p>

A new spin on an old drug could dent demand for Epidiolex, a marijuana-based epilepsy drug. Plus, here's how important Medicare and Medicaid are to UnitedHealth Group's profits.

<p>A new spin on an old drug could dent demand for Epidiolex, a marijuana-based epilepsy drug. Plus, here's&nbsp;how important&nbsp;Medicare and Medicaid are&nbsp;to&nbsp;UnitedHealth Group's profits.</p>

Healthcare: A Brewing Battleground in Epilepsy

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.

Share Healthcare: A Brewing Battleground in Epilepsy

Sign up to save your podcasts

Healthcare: A Brewing Battleground in Epilepsy

Healthcare: A Brewing Battleground in Epilepsy

More shows like Industry Focus

Motley Fool Money

Motley Fool Answers

Rule Breaker Investing

MarketFoolery